Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Stem Cells and Labeling for Spinal Cord Injury

Stem Cells and Labeling for Spinal Cord Injury

International Journal of Molecular Sciences, 2016 · DOI: 10.3390/ijms18010006 · Published: December 26, 2016

Spinal Cord InjuryRegenerative MedicineResearch Methodology & Design

Simple Explanation

Spinal cord injury (SCI) leads to degeneration of locomotor and sensory neurons. Stem cell therapy offers strategies for spinal cord repair, promoting remyelination and axonal elongation. However, optimized protocols and safety assays are needed before clinical application. Tracking stem cells after transplantation is crucial for determining their migration and viability. Cell tracking can be done by labeling cells with molecular probes or reporter genes. Each stem cell tracking modality has its own advantages and disadvantages, in terms of biocompatibility of molecular probes, detection thresholds, safety, and cost-effectiveness.

Study Duration
Not specified
Participants
Not specified
Evidence Level
Review

Key Findings

  • 1
    Stem cells can promote remyelination, neurite outgrowth, and axonal elongation after spinal cord injury.
  • 2
    SPIO labeling is used for stem cell tracking after SCI in preclinical and clinical studies, allowing detection of cell migration towards the injury site using MRI.
  • 3
    Reporter gene imaging, while requiring genomic manipulation, is an effective way to stably integrate markers into cells for PET and BLI imaging, allowing for serial transgene expression.

Research Summary

Stem cells represent a promising therapeutic approach for SCI, enhancing sensory and motor functions in animal models by promoting remyelination and axonal regeneration. Challenges remain in stem cell therapy for SCI, including the risk of teratoma formation with pluripotent stem cells and the need for pure populations of differentiated cells with efficient tracking systems. Improving stem cell labeling and tracking methods is crucial due to limited information about the location and survival of transplanted cells, with multimodal markers potentially providing optimal in vivo imaging and long-term tracking.

Practical Implications

Therapeutic Potential

Stem cell therapies hold significant promise for treating spinal cord injuries and improving patient outcomes.

Clinical Translation

Further research is needed to optimize stem cell differentiation protocols, improve tracking methods, and ensure safety before widespread clinical application.

Imaging Advancement

Multimodal imaging markers are needed to improve the accuracy of stem cell tracking, enabling a better understanding of cell fate and therapeutic efficacy.

Study Limitations

  • 1
    Risk of teratoma formation with pluripotent stem cells
  • 2
    Need for pure populations of differentiated cells
  • 3
    Inefficient tracking systems and moderate cell survival after transplantation

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury